Preferences
Related Series
Related Segments
Related Articles


PACS 2022
Changing Market Leads to Volatility among Large- to Small-Volume Organizations
Current Time Inside Cache Tag Helper: 12/6/2023 9:11:22 PM and Model.reportId = 2774
The US PACS market is poised for change. Several vendors have made or undergone acquisitions, and some vendors have large customer bases still on legacy solutions. Over 30% of the 368 organizations interviewed for this report are at risk of replacing their current vendor, and organizations are looking for vendor partners to advance their enterprise imaging strategies. Further, industry-wide staff shortages have led to support and innovation challenges among PACS vendors. This report examines how these vendors have addressed this shifting market’s challenges and met the needs of customers with large volumes (300,000+ studies per year) and small/midsize volumes (<300,000 studies per year).if you don't have a login, getting started is easy.
- Sectra Maintains Leading Customer Satisfaction across Small & Large Volumes; Early Indicators of Culture Shift
- Signs of Improvement from Fujifilm & Merative (IBM) Due to Increased Engagement
- For Philips Vue PACS & INFINITT, Satisfaction Gap Widens between Small and Large Customers
- Support Dips for Intelerad Customers amid Acquisitions; Change Healthcare Customers Unsure of Vendor’s Future
- GE Healthcare Being Replaced Due to Disengaged Relationships; Philips’ IntelliSpace PACS Customers on the Fence about Vue PACS
- Agfa HealthCare Rectifying Bumpy Rollout of Enterprise Imaging for Radiology; Many Large IMPAX Customers Still Hesitant to Move
Writer
Natalie Hopkins

Designer
Madison Moniz

Project Manager
Jill Wilcock
This material is copyrighted. Any organization gaining unauthorized access to this report will be liable to compensate KLAS for the full retail price. Please see the KLAS DATA USE POLICY for information regarding use of this report. © 2023 KLAS Research, LLC. All Rights Reserved. NOTE: Performance scores may change significantly when including newly interviewed provider organizations, especially when added to a smaller sample size like in emerging markets with a small number of live clients. The findings presented are not meant to be conclusive data for an entire client base.